Portfolio and pipeline
Multiparticulate pellet formulations.
Semi-finished, ready-to-fill pellet dosage forms. Search by molecule, or separate commercial manufacture from the development pipeline.
Loading the portfolio…
Portfolio and pipeline
Semi-finished, ready-to-fill pellet dosage forms. Search by molecule, or separate commercial manufacture from the development pipeline.
Loading the portfolio…
Showing 12 validated formulations
Active Molecule: Dried Ferrous Sulphate 150mg, Folic Acid 0.5mg, Zinc Sulphate 61.8mg
Triple-nutrient combination pellet formulation engineered with separating barrier layers for multiparticulate capsule filling.
Validated drug load
Dried FeSO4 150mg, Folic Acid 0.5mg, Zinc Sulphate 61.8mg
Standards: IP / Food Grade Standards
Active Molecule: Ferrous Fumarate 152mg IR, Zinc Sulphate Monohydrate 15mg IR, Folic Acid 1.5mg IR & Vitamin B12 15mcg
Multi-component combination pellet formulation manufactured with barrier film layers to support component stability in blended capsule fills.
Validated drug load
Ferrous Fumarate 152mg, ZnSO4 Monohydrate 15mg, Folic Acid 1.5mg, B12 15mcg
Standards: IP / Nutritional Standards
Active Molecule: Atorvastatin (10mg/20mg) & Clopidogrel Bisulphate (75mg)
Cardiovascular dual-drug multiparticulates combining antiplatelet and statin pellets into a single capsule fill.
Validated drug load
10mg/75mg & 20mg/75mg dose equivalent
Standards: In-house B2B Standard
Active Molecule: Esomeprazole EC (20mg/40mg) & Domperidone SR (30mg)
Gastro-resistant PPI with sustained-release prokinetic multiparticulates for capsule filling under development.
Validated drug load
20mg/30mg & 40mg/30mg dose equivalent
Standards: In-house B2B Standard
Active Molecule: Pantoprazole Sodium EC (20mg/40mg) & Domperidone SR (30mg)
Stabilized enteric pantoprazole combined with sustained release domperidone pellets under development.
Validated drug load
20mg/30mg & 40mg/30mg dose equivalent
Standards: In-house B2B Standard
Active Molecule: Pantoprazole EC (40mg) & Itopride HCl SR (150mg)
Enteric coated proton pump inhibitor combined with sustained release prokinetic pellets under development.
Validated drug load
40mg/150mg dose equivalent
Standards: In-house B2B Standard
Active Molecule: Pantoprazole EC (40mg) & Levosulpiride SR (75mg)
Enteric coated PPI combined with sustained-release prokinetic multiparticulates under development.
Validated drug load
40mg/75mg dose equivalent
Standards: In-house B2B Standard
Active Molecule: Rabeprazole Sodium EC (20mg) & Domperidone SR (30mg)
Enteric PPI blended with sustained release antiemetic pellets for capsule filling under development.
Validated drug load
20mg/30mg dose equivalent
Standards: In-house B2B Standard
Active Molecule: Rabeprazole Sodium EC (20mg) & Aceclofenac SR (100mg/200mg)
Gastro-protected NSAID dual system designed to mitigate ulcerogenic risks of chronic anti-inflammatory therapy.
Validated drug load
20mg/100mg & 20mg/200mg dose equivalent
Standards: In-house B2B Standard
Active Molecule: Rabeprazole Sodium EC (20mg) & Levosulpiride SR (75mg)
Enteric rabeprazole combined with sustained levosulpiride multiparticulates.
Validated drug load
20mg/75mg dose equivalent
Standards: In-house B2B Standard
Active Molecule: Rabeprazole Sodium EC (20mg) & Itopride HCl SR (150mg)
Prokinetic and PPI dual multiparticulates in fixed-ratio capsule fills.
Validated drug load
20mg/150mg dose equivalent
Standards: In-house B2B Standard
Active Molecule: Tamsulosin HCl SR (0.4mg) & Dutasteride IR (0.5mg)
Urological combo multiparticulates uniting alpha-blocker sustained release with 5-alpha reductase inhibitor.
Validated drug load
0.4mg/0.5mg dose equivalent
Standards: In-house B2B Standard